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Ab s t r Ac t
Background: Hepatitis E is mainly an acute and self-limiting disease which is endemic to resource poor regions of the world. Some patients 
have an increased susceptibility to develop fulminant hepatitis which is a rare disorder with high mortality and resource cost. In this study, a 
metabonomic approach was used to investigate the biochemical perturbation of the serum samples from acute liver failure patients induced 
by hepatitis E virus. Materials and Methods: Serum samples from hepatitis E virus-related acute liver failure patients (n = 20) and healthy 
controls (n = 20) were studied. Gas chromatography–mass spectrometry technique integrated with a commercial mass spectral library 
for the peak identification was used to detect the serum metabonome. Results: Out of the 24 metabolites detected, the serum levels of 
benzenepropanoic acid, lactic acid, hexadecanoic acid, L-proline, serine, and butanoic acid were significantly higher in the acute liver failure 
patients than those in the healthy control, whereas octadecanoic acid, N-formylglycine, and isoleucine were significantly higher in healthy 
controls compared to cases. These metabolites are suggested to be involved in various metabolic activities. Conclusion: These results may 
indicate that metabonomic analysis of the serum samples can provide integrative information to assess the severity of the liver failure, which 
is beneficial for predicting the pathogenetic condition and the course of liver disease.
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In t r o d u c t I o n
Acute liver failure is the clinical manifestation of sudden and severe 
hepatic injury. The main causal agent that triggers the onset of liver 
failure shows wide geographical variation and depends on the 
prevalent hepatotropic virus infection.[1,2] Hepatitis E is an acute and 
largely self-limiting form of viral hepatitis that is caused by hepatitis 
E virus (HEV). The virus is transmitted through fecal–oral route and 
is endemic throughout tropical and subtropical countries, with 
periodic epidemics through contaminated drinking water. Sporadic 
cases of viral hepatitis E infection also arise at much higher rates 
in endemic than in non-endemic regions.[3,4] Hepatitis E is now the 
most common cause of acute liver failure in India and Pakistan, 
China, and Southeast Asia.[5] Viral infections follow a more severe 
course, although children are infected, the highest attack rates are 
observed in young adults, aged 15–40 years.[6] Especially pregnant 
women show the propensity to develop acute hepatic failure with 
high mortality.[7,8] Liver is the main metabolic, biosynthetic, storage, 
and detoxifying organ, its infection by HEV causes a broad range of 
clinical manifestations, most of which are related to hepatocellular 
damage.[6] Hepatitis E patients show the differential expression of 
various acute-phase proteins that are synthesized in the liver, in their 
plasma, and urine.[9] Liver being a major metabolic organ, its infection 
is also expected to result in measurable changes in metabolite levels.
The information obtained from metabonomic study is also 
complementary to that from proteomics and genomics. Recent 
advances in analytical techniques have enhanced the capability 
for the global assessment of entire classes of biomolecules such 
as genome, proteome, and metabonome. For understanding and 
elucidating the etiology and mechanisms of human diseases, 
molecular systems biology has been proposed as an alternative 
and promising resolution.[10] Metabonomics, defined as “the 
quantitative measurement of the multiparametric metabolic 
response of living systems to pathophysiological stimuli or 
genetic modification,”[11,12] is a novel methodology arising from 
the post-genomics era for the study of molecular systems 
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biology. Nowadays, metabonomics has been applied to various 
biomedical and toxicological studies. Because the alteration of 
the physiological status can disrupt homeostasis, resulting in 
perturbations of the levels of endogenous biochemicals involved 
in different kinds of key metabolic processes, the metabonomic 
study may provide both invaluable information to understand the 
molecular mechanisms and provide novel insights into the status 
of dysfunction in biological system.
The “-omics” approaches, especially the proteomics with the 
global analysis of protein expression, have been employed to screen 
the molecular markers which can be used as serological biomarkers. 
Because liver failure will induce severe metabolic disturbance, 
it is generally believed that the comprehensive detection and 
characterization of the alternative endogenous metabolites may 
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be useful to develop the metabolic phenotyping of liver diseases. 
In this study, we applied gas chromatography–mass spectrometry 
(GC–MS) technique to profile the metabolic composition of serum 
samples from both healthy subjects and HEV-induced liver failure 
patients. The detailed analysis of metabonomic data with pattern 
recognition techniques may reveal valuable information for the 
diagnosis and therapy of liver failure patients.
MAt e r I A l s A n d Me t h o d s
Patients and Controls
Twenty HEV-induced acute liver failure patients visiting the 
medical OPD of the Department of Medicine, Lok Nayak Hospital, 
New Delhi, between February 2012 and February 2015 were 
enrolled in this study with the patients’ consent. All of the patients 
had severe liver malfunction with hepatic encephalopathy. The 
control serum samples from 20 healthy volunteers were collected. 
After the centrifugation (3000 rpm) for 10 min at 4°C, the serum 
samples were stored at –80°C until use.
Sample Preparation
The serum samples were thawed at room temperature. A 300 µL 
aliquot of acetonitrile was added into 200 µL of sera to precipitate 
the protein, and the mixture was shaken vigorously for 30 s. After it 
was kept on ice for 5 min, the mixture was ultrasonically extracted 
for 10 min and then followed by centrifugation (10,000 rpm) for 
10 min at 4°C. Then, 300 µL supernatant was transferred to the GC 
vial and evaporated to dryness under a stream of nitrogen gas. The 
chemical derivatization of the serum metabonome was carried 
out using the combination of methoxymation and silylation. A 
50 µL aliquot of methoxyamine pyridine solution (15 µg/µL) was 
added into the vial. The methoxymation was performed at room 
temperature for 16 h. Then, 90 µL of MSTFA with 1% TMCS as 
catalyst was added to the vial. After the silylation for 1 h at room 
temperature, 150 µL of n-heptane was added into each GC vial to 
dilute the solution. The sample solution was transferred to the GC 
microvial for GC–MS analysis after filtration.
GC–MS Analysis
A 2.0 µL aliquot of the derivatized sample was injected with 
splitless mode by an Agilent 7683 Series autosampler (Agilent 
Technologies) into an Agilent 6980 GC system equipped with a 
fused-silica capillary column chemically (30 m × 0.25 mm i.d.) 
bonded with 0.25 µm ZB-5MS stationary phase (Phenomenex). 
The injector temperature was set at 270°C. Helium (He) was used 
as the carrier gas with a constant flow rate set at 0.8 mL/min 
through the column. To acquire a well separation, the column 
temperature was initially maintained at 70°C for 5 min and then 
increased from 70 to 100°C at a rate of 10°C/min for 5 min. Then, 
the column temperature was increased to 200°C at 10°C/min 
for another 5 min. After that, the temperature was increased to 
280°C at 10°C/min and held for 10 min. The column effluent was 
introduced into the ion source of an Agilent 5973 mass selective 
detector (Agilent Technologies). The temperature of the ion source 
was set at 230°C, and for the quadrupole, it was set at 150°C. MS 
detection was implemented with electron impact mode and full 
scan monitoring mode (m/z 60–600). AMDIS software (National 
Institute of Standards and Technology, Gaithersburg, MD) was 
used for the peak deconvolution. Identification of the interested 
peaks was supported by NIST v1.0.0.12 mass spectra library.
Data Processing and Pattern Recognition
The serum samples from the patient group and control group were 
blindly analyzed in a random order. Each sample was represented 
with a GC–MS total ion current (TIC) chromatogram, and the peaks 
with the intensity higher than 3-fold of the ratio of signal-to-noise 
were detected.
Statistical Analysis
Statistical analyses were performed using online GraphPad 
software. Values are represented as mean± SD; significant 
difference between the HEV patients and healthy group was 
assessed using the two-tailed Student’s t-test; P = –0.05 was 
considered statistically significant.
re s u lts A n d dI s c u s s I o n
GC–MS Analysis of Serum Samples
GC–MS TIC chromatograms of serum samples from the HEV-related 
acute liver failure patient group and healthy controls are shown in 
Figures  1 and 2. In these chromatographic profiles, endogenous 
metabolites such as amino acids, fatty acids, organic acids, and 
carbohydrates were identified based on the NIST mass spectra 
library. These components are involved in multiple biochemical 
processes, especially the energy metabolism, protein metabolism, 
amino acid metabolism, and lipid metabolism.
Approximately 80% of the amino acids were absorbed 
form digestive tract used in the process of protein synthesis, 
deamination, and transamination in liver.[13] As shown in Table 1, 
in the liver failure patients, the concentration of multiple amino 
acids was increased in the serum samples. Mainly when the 
liver is injured, the metabolic enzymes of amino acids may be 
damaged and the normal metabolic pathway of the amino acids is 
deteriorated results in increased amino acids in serum. Moreover, 
when the process of protein synthesis in the liver was disturbed, 
the absorption of the amino acids into the liver from the blood was 
decreased. Furthermore, the increase of amino acids in the blood 
was enhanced by plasmatorrhexis and necrobiosis from hepatic 
cells. In addition, glucose, proteins, and lipids were absorbed 
less in liver failure patients, amino acids will be generated by the 
decomposition of endogenous proteins for energy metabolism 
further leads to increase amino acids in the blood.
Serum levels of benzenepropanoic acid, lactic acid, 
hexadecanoic acid, l-proline, serine, and butanoic acid were 
significantly higher in the acute liver failure patients than those 
in the healthy control [Table  1], whereas octadecanoic acid, 
N-formylglycine, and isoleucine were significantly higher in healthy 
controls compared to cases [Table  1]. These metabolites are 
suggested to be involved in energy metabolism, lipid metabolism, 
protein metabolism, and amino acid metabolism.
In clinical diagnosis of liver failure cases, the liver function 
examination which is used is limited by small number of 
parameter and is insufficient to give comprehensive information 
about the physiopathological state. There is a lack of global index 
for evaluation of the severity of liver disease and prognosis. A 
rapid diagnosis in clinical practice is beneficial for improving the 
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Figure 1: Gas chromatography–mass spectrometry total ion current profile of serum metabolites of hepatitis E virus patient group. The 
identified peaks are listed in Table 1
Figure 2: Gas chromatography–mass spectrometry total ion current profile of serum metabolites of healthy group. The identified peaks are 
listed in Table 1
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patient care quality and reducing the health-care costs. In this 
study, we attempted to use metabonomic approach based on 
the GC–MS technique to evaluate the physiopathologic state of 
acute liver failure patients for clinical diagnosis and prognosis. 
The result of multivariate analysis of the metabonomic data 
showed that the metabolism pattern of the acute liver failure 
patients was distinctive from the healthy control group [Figures 3 
and 4]. These results may indicate that metabonomic analysis 
of the serum samples can provide integrative information to 
assess the  severity of the liver failure, which is beneficial for 
predicting  the pathogenetic condition and the course of liver 
disease.
Table 1: Serum metabolites of the hepatitis E virus-related acute liver failure patients and healthy group measured by gas chromatography–
mass spectrometry
Peak no. Retention time Metabolites Patient group (n=20) Healthy group (n=20)
1 25.72 Octadecanoic acid 1.8e7±2.7e7 4.9e6±4.7e6*
2 20.59 Octadecadienoic acid 4.3e7±2.9e7 4.6e7±4.2e7
3 17.83 Benzenepropanoic acid 5.0e6±5.1e6 1.0e8±2.2e8**
4 10.87 Butanedioic acid 8.9e6±4.3e6 1.1e7±5.7e6**
5 26.98 Cholesterol 6.2e7±1.3e8 2.9e7±7.6e7
6 7.18 Lactic acid 7.7e7±1.7e8 2.5e7±6.3e7**
7 22.51 Ethanedioic acid 1.4e6±2.9e6 1.2e6±1.1e6
8 7.87 Glycine 9.8e7±5.1e7 3.0e6±6.8e6**
9 19.09 Hexadecanoic acid 6.4e8±3.1e8 2.2e8±1.6e8**
10 8.71 Isoleucine 5.8e6±2.8e6 9.8e6±3.5e6**
11 7.52 I-Alanine 1.5e7±9.8e7 2.6e7±1.5e7
12 8.37 l-Leucine 1.2e7±7.3e7 1.8e7±1.0e7
13 13.62 L-Proline 5.5e7±2.6e7 2.6e7±2.1e7**
14 14.26 L-Threonic acid 6.6e6±4.1e6 8.1e6±3.3e6
15 7.11 l-Valine 1.5e7±1.2e7 1.6e7±1.5e7
16 19.81 Myo-inositol 1.4e7±1.1e7 2.2e7±1.9e7
17 19.25 N-Formylglycine 4.3e6±1.4e7 7.8e5±5.0e5**
18 14.32 Pentanedioic acid 1.3e7±5.3e7 2.3e7±2.6e7
19 16.52 Phosphoric acid 1.0e7±1.1e7 1.4e7±1.4e7
20 6.50 Propanoic acid 1.8e8±3.5e8 1.9e7±2.6e7
21 10.04 Serine 6.7e7±4.9e7 2.4e7±5.7e7*
22 20.31 2-Octenoic acid 8.4e5±1.1e5 6.7e5±6.8e5
23 17.43 Sorbitol 5.0e7±5.7e7 4.6e7±2.9e7
24 16.599 Butanoic acid 3.1e7±1.3e7 2.0e7±1.2e7**
The relative intensity of serum metabolites in the healthy and patients group is expressed with their peak area. Values are represented as mean±SD; significant 
difference between the hepatitis E virus patients (20) and healthy group (20) is based on the two-tailed Student’s t-test (*P<0.05, **P≤0.01). Serum metabolites 
were identified based on NIST mass spectra database
Figure 3: Over laid gas chromatography–mass spectrometry total ion current profile of serum metabolites of hepatitis E virus patients and 
healthy group
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co n c lu s I o n
In the current study, the result of multivariate analysis of the 
metabonomic data may indicate that the serum samples can 
provide integrative information to assess the severity of the liver 
failure, which is beneficial for predicting the pathogenesis and the 
course of liver disease.
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Figure 4:  Over laid gas chromatography–mass spectrometry total ion current profile of serum metabolites of hepatitis E virus patients and 
healthy group, a peak with significant difference zoomed in
